Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tianjin Zhongxin Pharma Group | Singapore | Healthcare | Pharmaceuticals | SGD 4.01B | 6.2x | 0.08 | SGD 3.13 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Haw Par Corporation Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 2.65B | 11.6x | 2.14 | SGD 11.98 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hyphens Pharma | Singapore | Healthcare | Pharmaceuticals | SGD 100.39M | 10.8x | 0.56 | SGD 0.32 | 3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Pharmesis International Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 15.85M | 10x | 0.04 | SGD 0.50 | 16.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IX Biopharma Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 14.21M | -1.8x | -0.25 | SGD 0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suntar Eco-City Ltd | Singapore | Healthcare | Pharmaceuticals | SGD 7.97M | 5.5x | 0 | SGD 0.13 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |